Biotech

All Articles

Eli Lilly leaps deeper right into AI along with $409M Genetic Leap offer

.Eli Lilly has vaulted right into an AI-enabled drug breakthrough offer, partnering along with RNA p...

After FDA denial and also discharges, Lykos chief executive officer is actually leaving

.Lykos chief executive officer as well as owner Amy Emerson is actually leaving, with principal func...

Novartis kindles brand-new phase of Voyager deal along with $15M capsid deal

.Novartis is opening a brand new outpost in its cooperation along with Voyager Therapeutics, spendin...

Lilly messages extra positive information on its own regular the hormone insulin prospect

.On the heels of an FDA turndown for its own main rival Novo Nordisk, Eli Lilly is actually pulling ...

IN 8bio stops phase 2 trial, gives up half of staff

.Only a couple of months after application the 1st client in a stage 2 test for newly detected gliob...

Lilly, Haya ink $1B biobuck excessive weight deal to search dark genome

.Eli Lilly's hunt for weight problems targets has led it to the dark genome. The Big Pharma has actu...

ArsenalBio elevates $325M, rotates away from previous lead resource

.Arsenal Biosciences is actually proceeding up. The tissue treatment firm has added on $325 thousand...

Lilly- supported fat burning biotech documents IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually su...

Aelis' cannabis make use of medication fails stage 2b, driving Indivior to reconsider $100M alternative

.Aelis Farma's chances of protecting a fast, favorable decision on a $100 million possibility paymen...

ProKidney halts period 3 trial certainly not required for tissue treatment confirmation

.ProKidney has actually stopped among a set of stage 3 trials for its cell treatment for renal healt...